{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6Wg7wIDA","lastupdate":"2022-10-17T00:00:00.000Z","update_date":"2022-10-17T00:00:00.000Z","lastModified":"Mar 19, 2025","active":1,"confidence_score":100,"confidence_score_reason":"funding rounds, markets","urlname":"eybna-technologies","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$j20cEWfP6CjeB1He4kkakcCmrjvKiwRN2mQiyZ03ry6BPt9Fnh95ql","name":"Eybna Technologies","oneliner":"Terpene | Wellness | Food Tech | Cannabis","registrar":"515146454","website":"https://eybna.com","careerspage":"https://eybna.com/careers","founded_month":10,"founded_year":2014,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/eybna","youtube":"https://www.youtube.com/channel/UCsNnQ0zMOzGjgDeKr1s5QAg","facebook":"https://www.facebook.com/eybna","linkedin":"https://www.linkedin.com/company/8544085","instagram":"https://www.instagram.com/eybna"},"social":["https://www.linkedin.com/company/8544085","https://www.facebook.com/eybna","https://twitter.com/eybna","https://www.youtube.com/channel/UCsNnQ0zMOzGjgDeKr1s5QAg","https://www.instagram.com/eybna"],"flattenedsociallinks":"https://www.linkedin.com/company/8544085|https://www.facebook.com/eybna|https://twitter.com/eybna|https://www.youtube.com/channel/UCsNnQ0zMOzGjgDeKr1s5QAg|https://www.instagram.com/eybna","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":64,"patent":1,"raised":0,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["ebnya","Ebyna","eynba"],"about":"Eybna is a technology company and terpene manufacturer. Eybna's R&D center aims to contribute to the health of mankind by utilizing the therapeutic benefits of cannabis phytochemicals, with a focus on terpenes. \r\n\r\nEybna's partnerships with academia and industry partners allow the company to constantly integrate advanced research into product development, transforming valuable scientific knowledge into easily applicable products, for the immediate benefit of people worldwide. \r\n\r\nEybna has an R&D center based in Israel and a US office based in California.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"3feb2794-b2f7-49fc-81f5-e79bb53f7b1f","city":"Kefar Sava","type":null,"address":"Ha-Yozma St 1, Kefar Sava, 4442529, Israel","placeid":"ChIJUeRwcaI5HRUR4vQAkTNwwRU","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"0e8d971b-4f16-4785-a8cc-d27f3577a8ac","city":"Los Angeles","address":"7647 Hayvenhurst Ave, Van Nuys, CA 91406, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"QdlT2aFwUZX8kAhx9fty1eprGlcmXzcl8o7h36aBaZwQMNbKh3u3Ag","date":"Jun 22, 2022","link":"https://cannatechtoday.com/new-research-into-terpenes-could-change-medicine-forever/","source":"cannatechtoday.com","visible":1,"analysis":{"tags":["cannabis science","research","terpenes","cannabinoids","endocannabinoid system","coronavirus","phytochemical formulations","wellness","medical cannabis","data science","receptor-specific formulations","industry","innovation"],"company":"Eybna Technologies","layoffs":null,"summary":"The article discusses the pioneering work of Eybna Technologies in the field of cannabis science. Eybna has made significant discoveries in the study of terpenes, cannabinoids, and their interactions with the endocannabinoid system. In 2020, Eybna discovered a cannabinoid formulation that effectively blocked the novel coronavirus from penetrating living cells. They are now conducting clinical studies on the formulation as a potential treatment for COVID-19. Eybna has also developed receptor-specific cannabinoid formulations, which are unique in the industry. These formulations target specific wellness goals and are composed of ingredients that are effective for producing certain effects, such as pain relief or sleep. Eybna plans to introduce these formulations globally and partner with other companies in the cannabis and CBD industry. The article emphasizes the potential of the cannabis industry to bring about change and innovation in the pharmaceutical industry and improve the quality of life on a global scale.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["cannabis science","terpenes","cannabinoids","coronavirus","phytochemical formulations"],"date_of_event":"2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"sW62TmuajM4qjs79Zi7NaZaCmZGpNMezEPbHGoXyBDhK7LwoQxPvJ8","news_summary":"New Research Into Terpenes Could Change Medicine Forever","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"CmgDERLyfa6YDvmJSg3Bo6AqSExk6hd8DkzVGYS6Se2BrWsFleVGwh","date":"Nov 22, 2021","link":"https://www.prnewswire.com/news-releases/eybna-an-international-technology-company-establishes-cooperation-with-gat-foods-ibbl-part-of-cbc-group---the-largest-beverage-company-in-israel---to-develop-a-new-category-of-functional-beverages-301429116.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Eybna","layoffs":null,"summary":"Eybna has been selected as an R&D partner by Gat Foods (IBBL) to create functional beverages using terpene formulations. The partnership marks a major milestone in the international functional beverage industry. The Global Functional Beverage Market is projected to be worth USD 198 billion by 2026. Eybnas new Receptor Specific™ Line, which offers botanical formulations for various wellness needs, was launched in October 2021. The R&D partnership between Eybna and Gat Foods (IBBL) will begin with a commercial pilot in Israel and expand to other countries. Eybna is a technology company specializing in botanical medicine, while Gat Foods (IBBL) is one of the largest beverage manufacturers and distributors in Israel.","partners":"Gat Foods (IBBL)","customers":null,"investors":null,"confidence":9,"key_topics":["Research and Development","Functional Beverages","Wellness Market","Terpene Formulations","Global Functional Beverage Market"],"date_of_event":"2021-11-22","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Hlt1UOVPu9tzmmJxCfCyXdoNlcVy5DGWqMqSMqVuQGBg4gXgfhTLc0","news_summary":"Eybna, an International Technology Company, Establishes Cooperation with Gat Foods (IBBL), part of CBC group - the Largest Beverage Company in Israel - to Develop a New Category of Functional Beverages","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"DekBjvEqkmbNDg7mUt5sqF7PA3JKw93jJSsLWJV6VqfvMk9oIMoTxA","date":"Oct 20, 2021","link":"https://www.prnewswire.com/news-releases/international-technology-company-eybna-empowers-the-next-generation-of-wellness-products-with-receptor-specific-formulations-301404768.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Product Launch","company":"Eybna","layoffs":"N/A","summary":"Eybna, a technology company specializing in cannabis and botanical medicine, has launched its Functional Line. The line includes data-driven phytochemical formulations designed to meet wellness needs such as focus, sleep, anxiety, pain, inflammation, and mood management. The formulations are the result of nearly a decade of scientific research and biological data analysis. The launch includes 10 Receptor-Specific terpene and cannabinoid proprietary formulations. Eybnas CEO and Co-founder, Nadav Eyal, stated that the new line of formulations is an important milestone in Eybnas efforts towards predictable cannabis consumption.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Functional Line","Phytochemical Formulations","Wellness Needs","Receptor-Specific Formulations","Cannabis Consumption"],"date_of_event":"Oct. 20, 2021","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SqZDUYsmP7rgtRwlQ1Nhd3KcVA2SAsSq3cPMSfjnlux9iLQRH50wdM","news_summary":"International Technology Company Eybna Empowers the Next Generation of Wellness Products with Receptor-Specific™ Formulations","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bce6754b-842e-44f4-b026-e658d7e064da","date":"Aug 6, 2020","link":"https://www.healtheuropa.eu/successful-initial-results-using-cannabis-terpenes-to-treat-covid-19/101986/","source":"www.healtheuropa.eu","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"9oUGgMiHW4MCPVTzlF8A0FUsSfR8RS073r35wtZC5VAqfTr2XXP9wW","news_summary":"Successful initial results using cannabis terpenes to treat COVID-19","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"d34399a1-2d3b-4b82-bce0-c1a380594b9a","date":"Jul 2, 2020","link":"https://www.israel21c.org/can-we-be-cured-of-illness-by-the-smell-of-cannabis/","source":"www.israel21c.org","visible":1,"analysis":{"tags":["terpenes","cannabis","phytochemicals","medical cannabis","terpene formulations"],"company":"Eybna","layoffs":null,"summary":"Israeli company Eybna specializes in terpene formulations for the cannabis industry. Terpenes are organic compounds that give scents, tastes, and health benefits to fruits, flowers, and plants, including cannabis. Eybnas proprietary terpene-based formulations are used by manufacturers in the cannabis space to enhance their products. The companys research focuses on the therapeutic properties of terpenes and other cannabis phytochemicals. Eybna offers customized terpene formulations for specific sensations or medical needs. They are also collaborating with CannaSoul Analytics to investigate terpenes as an antiviral treatment for COVID-19. Eybnas growth is positive, as more companies are interested in incorporating terpenes into their products.","partners":["Seach Medical Group","CannaSoul Analytics"],"customers":null,"investors":null,"confidence":8,"key_topics":["terpenes","cannabis","medical benefits","research","antiviral treatment"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FVmCbxrdmX7D0XEW7iV6vnVc0MFaSGoXyaEcAmTvVMYFlT9VudNLY3","news_summary":"Can the smell of cannabis cure us of illness?","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"434c0dcf-240c-4fa8-bdfe-cb522a5bbd96","date":"Apr 22, 2020","link":"https://www.prnewswire.com/news-releases/eybna-and-cannasoul-top-cannabis-rd-firms-join-forces-to-prove-a-proprietary-terpene-formulation-for-treating-viral-infections-via-modulation-of-cytokine-storm-301045499.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"collaboration, terpene formulation, COVID-19","company":"CannaSoul and Eybna Technologies Ltd","layoffs":null,"summary":"CannaSoul and Eybna Technologies have collaborated to develop a terpene formulation for treating COVID-19. CannaSoul, a global leader in cannabis research and development, will utilize its analytical expertise to customize Eybnas NT-VRL™ terpene formulation for optimizing its anti-inflammatory and anti-viral properties. The collaboration aims to provide effective treatment options for high-risk populations and actively ill patients. CannaSoul is also conducting studies to identify cannabis molecules that can suppress the immune response to the virus and reduce the expression of the ACE2 receptor, which allows the virus to enter human cells. Eybnas NT-VRL™ formulation, composed of specific terpenes, has proven anti-viral and anti-inflammatory properties. The formulation is intended to be used via inhalation for increased bioavailability.","partners":"Eybna Technologies Ltd","customers":null,"investors":null,"confidence":8,"key_topics":["CannaSoul","Eybna","terpene formulation","COVID-19","collaboration"],"date_of_event":"April 22, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vucU4PSbx4Gb35OYfJqkxmxCQsCtUbUi0eWqm1gTIyDynZrFo9EwUv","news_summary":"Eybna and CannaSoul, Top Cannabis R&D Firms, Join Forces to Prove a Proprietary Terpene Formulation for Treating Viral Infections via Modulation of Cytokine Storm","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"42cecb8b-f31b-4353-97ac-82b5c5e93952","date":"Jul 18, 2019","link":"https://www.prnewswire.com/news-releases/terpenes-eybna-technologies-unlock-the-medicinal-wonders-of-cannabis-300887364.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["terpenes","cannabis","medicinal qualities","research","industry"],"company":"Eybna","layoffs":null,"summary":"The article discusses the importance of terpenes in cannabis products and their medicinal qualities. Eybna, a company based in Israel and Los Angeles, is at the forefront of researching terpene properties and producing advanced terpene products. The company aims to improve the medicinal benefits of cannabis through its discoveries and collaborations with scientific institutions. The article highlights the potential of terpenes in unlocking the true power of the cannabis plant and their value in the growing cannabis industry. Eybnas focus on terpenes is expected to be a game changer in the medical and cannabis industry.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["terpenes","cannabis","medicinal qualities","research","industry"],"date_of_event":"July 18, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Tipi6vlSVhKkwsLEfWLYDIYBZK794fmqEh4ApfDsOQx1WozPWCzxEs","news_summary":"Terpenes: Eybna Technologies Unlock the Medicinal Wonders of Cannabis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"events":null,"techcommunityinvolvement":null,"mediagallery":[{"id":"qXtJPkH9ESnbY0or9bC4RCpBI6HyMFho88KKpgrhpyTyVVRjuGkkr8","timestamp":"2022-10-17 14:37:10.000000","resources_type":2,"resources_title":"","resources_file_name":"qejjc1MXml0","alt":"","imageurl":"https://img.youtube.com/vi/qejjc1MXml0/0.jpg","url":"http://youtu.be/qejjc1MXml0"},{"id":"19ae82ca-e2de-44df-a1f6-bd12cbd866de","timestamp":"2019-04-03 13:16:16.000000","resources_type":2,"resources_title":"Nadav Eyal - Eybna Technologies on Bio Control Program in Cannabis","resources_file_name":"mgIhjd45Cec","alt":"Nadav Eyal - Eybna Technologies on Bio Control Program in Cannabis logo","imageurl":"https://img.youtube.com/vi/mgIhjd45Cec/0.jpg","url":"http://youtu.be/mgIhjd45Cec"}],"tags":["natural-active-ingredients","food-ingredients","cannabis","pharmaceuticals","herbal-medicine","pharma-companies","food-and-beverage"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B2C","B2B"],"productstage":"Released","products":["Diol","Skunk","Elite","Live Line","Kash","Azul","Haze"],"geomarkets":["United States","Israel"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Mature","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Nadav Eyal","email":"nadav@eybna.com","phone":"0505929007","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgO7DnasIDA","bounced":false,"claimed":1,"founder":1,"urlname":"nadav-eyal","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAnp-X1AgM","position":"Co-Founder & CEO","last_name":"Eyal","claimtoken":"b37956547c3c4b8c63efd4eeb3cb0ea2e49e923ca6b24c4427fca3c0c5470020","first_name":"Nadav","picturekey":"$OOyZ89Enj2k0AVsiNK3XcWcA0SOULI4oTORhkTMp98biHk1VZC9r5v","claimeddate":"2015-02-15","linkedinurl":"https://www.linkedin.com/in/nadav-eyal-1ab21941","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$OOyZ89Enj2k0AVsiNK3XcWcA0SOULI4oTORhkTMp98biHk1VZC9r5v","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Avichai Elbaz","email":"avichai@eybna.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwO25kY4JDA","bounced":false,"claimed":0,"founder":0,"urlname":"avichai-elbaz","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgxoSxxQkM","position":"VP Sales","last_name":"Elbaz","claimtoken":"CaX7vAqP0Y7CSsX9Mi4mVBATnOgEF4GcpXEE9ft2TjPbnV6SaESuNg","first_name":"Avichai","picturekey":"$07GTeRGqo8YB2NWyqizyqlhCX0Jc9f67Y3FVJwa5nw2k17VoXr7GpU","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/avichaielbaz","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-17 14:32:59.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$07GTeRGqo8YB2NWyqizyqlhCX0Jc9f67Y3FVJwa5nw2k17VoXr7GpU","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Gil Onn","email":"gil@eybna.com","phone":"","gender":"Male","userid":"zAJ8jpHVYNDUQFn16HR4tU6Y5DhT8h3Lht1eZ4SsuLG2D33xTdBkLC","bounced":false,"claimed":1,"founder":0,"urlname":"gil-onn-1","visible":1,"memberid":"QL5bVFIp0ubQg2nG2BlKN6pADJ6vzqGhv6ByrEAWBxr3dlFS6xaDlS","position":"Head of Marketing & Design","last_name":"Onn","claimtoken":"Qrs0GgqJQQKVfu0lkfsw9cftdukK0asmfhZl1YAeoeVAmdLsoRjtfo","first_name":"Gil","picturekey":"$KTo821I2oXRky9ei29Geu53Kgy7SXebce6z33EJjXdkyswLpC6LDjy.png","claimeddate":"2025-03-19","linkedinurl":"https://www.linkedin.com/in/gil-onn/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-03-19 11:50:57.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$KTo821I2oXRky9ei29Geu53Kgy7SXebce6z33EJjXdkyswLpC6LDjy.png","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-05-19T00:00:00.000Z","crunchbaseid":"eybna-technologies-ltd","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yamila Silbert","creator_email":"yamila.urwicz@gmail.com","createdate":"2015-02-15T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/2014","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Eybna Technologies","logourl":"https://storage.googleapis.com/clean-finder-353810/$j20cEWfP6CjeB1He4kkakcCmrjvKiwRN2mQiyZ03ry6BPt9Fnh95ql","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$j20cEWfP6CjeB1He4kkakcCmrjvKiwRN2mQiyZ03ry6BPt9Fnh95ql","seoabout":"Eybna is a technology company and terpene manufacturer. Eybna's R&D center aims to contribute to the health of mankind by utilizing the therapeutic benefit...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Herbals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"},{"title":"Medical Cannabis","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Medical Cannabis"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"},{"title":"Biotechnology","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Herbals","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Herbals"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Herbals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQlIIIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development","Medical Cannabis"],"coreTechnology":["Biologicals","Herbals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}